Recent progress in psychiatric genetics - Some hope but no hype

Human Molecular Genetics

Volumn 9, Issue 6, 2000, Pages 927-935

  Stoltenberg, Scott F ^a   Burmeister, Margit ^b,c,d  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN; SEROTONIN TRANSPORTER;

ALCOHOLISM; AUTISM; CHROMOSOMAL LOCALIZATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INHERITANCE; MENTAL DISEASE; PLEIOTROPY; PRIORITY JOURNAL; PROMOTER REGION; PSYCHOPHARMACOLOGY; REVIEW; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM;

EPISTASIS, GENETIC; GENETIC MARKERS; HUMANS; LINKAGE (GENETICS); MENTAL DISORDERS; PHENOTYPE; QUANTITATIVE TRAIT, HERITABLE;

EID: 0034639939     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (149)

1. NIMH Workgroup (1999) Genetics and mental disorders. National Institute of Mental Health's Genetics Workgroup. Biol. Psychiatry, 45, 559-573.
2. Tarantino, L. and Bucan, M. (2000) Dissection of behavior and psychiatric-disorders using the nouse as a model. Hum. Mol. Genet., 9, 953-965.
3. Gottlieb, G., Wahlsten, D. and Lickliter, R. (1998) The significance of biology for human development: a developmental psychobiological systems view. In Damon, W. and Lerner, R. (eds), Handbook of Child Psychology: Theoretical Models of Human Development. Wiley, New York, NY, pp. 233-273.
4. Van Camp, G., Willems, P.J. and Smith, R.J. (1997) Nonsyndromic hearing impairment: unparalleled heterogeneity. Am. J. Hum. Genet., 60, 758-764.
5. Steel, K.P. and Bussoli, T.J. (1999) Deafness genes: expressions of surprise. Trends Genet., 15, 207-211.
6. Lander, E.S. and Schork, N.J. (1994) Genetic dissection of complex traits. Science, 265, 2037-2048.
7. Risch, N. (1990) Linkage strategies for genetically complex traits. I. Multilocus models. Am. J. Hum. Genet., 46, 222-228.
8. Gershon, E.S. (2000) Bipolar illness and schizophrenia as oligogenic diseases: implications for the future. Biol. Psychiatry, 47, 240-244.
9. Craddock, N. and Jones, I. (1999) Genetics of bipolar disorder. J. Med. Genet., 36, 585-594.
10. Lamb, J.A., Moore, J., Bailey, A. and Monaco, A.P. (2000) Autism: recent molecular genetic advances. Hum. Mol. Genet., 9, 861-868
11. Risch, N., Spiker, D., Lotspeich, L., Nouri, N., Hinds, D., Hallmayer, J., Kalaydjieva, L., McCague, P., Dimiceli, S., Pitts, T. et al. (1999) A genomic screen of autism: evidence for a multilocus etiology. Am. J. Hum. Genet., 65, 493-507.
12. Nathan, P.E. and Langenbucher, J.W. (1999) Psychopathology: description and classification. Annu. Rev. Psychol., 50, 79-107.
13. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC.
14. Kendler, K.S., Karkowski, L.M. and Walsh, D. (1998) The structure of psychosis: latent class analysis of probands from the Roscommon Family Study. Arch. Gen. Psychiatry, 55, 492-499.
15. Merikangas, K.R., Mehta, R.L., Molnar, B.E., Walters, E.E., Swendsen, J.D., Aguilar-Gaziola, S., Bijl, R., Borges, G., Caraveo-Anduaga, J.J., DeWit, D.J. et al. (1998) Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict. Behav., 23, 893-907.
16. Bierut, L.J., Dinwiddie, S.H., Begleiter, H., Crowe, R.R., Hesselbrock, V., Nurnberger, J.I., Jr. Porjesz, B., Schuckit, M.A. and Reich, T. (1998) Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism. Arch. Gen. Psychiatry, 55, 982-988.
17. Swillen, A., Devriendt, K., Legius, E., Prinzie, P., Vogels, A., Ghesquiere, P. and Fryns, J.P. (1999) The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence. Genet. Couns., 10, 79-88.
18. Papolos, D.F., Faedda, G.L., Veit, S., Goldberg, R., Morrow, B., Kucherlapati, R. and Shprintzen, R.J. (1996) Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am. J. Psychiatry, 153, 1541-1547.
19. Carlson, C., Papolos, D., Pandita, R.K., Faedda, G.L., Veit, S., Goldberg, R., Shprintzen, R., Kucherlapati, R. and Morrow, B. (1997) Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders. Am. J. Hum. Genet., 60, 851-859.
20. Chudley, A.E., Gutierrez, E., Jocelyn, L.J. and Chodirker, B.N. (1998) Outcomes of genetic evaluation in children with pervasive developmental disorder. J. Dev. Behav. Pediatr., 19, 321-325.
21. Karayiorgou, M., Morris, M.A., Morrow, B., Shprintzen, R.J., Goldberg, R., Borrow, J., Gos, A., Nestadt, G., Wolyniec, P.S., Lasseter, V.K. et al. (1995) Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q 11. Proc. Natl Acad. Sci. USA, 92, 7612-7616.
22. Bassett, A.S. and Chow, E.W. (1999) 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol. Psychiatry, 46, 882-891.
23. Lachman, H.M., Kelsoe, J.R., Remick, R.A., Sadovnick, A.D., Rapaport, M.H., Lin, M., Pazur, B.A., Roe, A.M., Saito, T. and Papolos, D.F. (1997) Linkage studies suggest a possible locus for bipolar disorder near the velo-cardio-facial syndrome region on chromosome 22. Am. J. Med. Genet., 74, 121-128.
24. Lasseter, V.K., Pulver, A.E., Wolyniec, P.S., Nestadt, G., Meyers, D., Karayiorgou, M., Housman, D., Antonarakis, S., Kazazian, H., Kasch, L. et al. (1995) Follow-up report of potential linkage for schizophrenia on chromosome 22q: part 3. Am. J. Med. Genet., 60, 172-173.
25. Tsuang, M.T., Stone, W.S. and Faraone, S.V. (1999) Schizophrenia: a review of genetic studies. Harv. Rev. Psychiatry, 7, 185-207.
26. Lachman, H.M., Papolos, D.F., Saito, T., Yu, Y.M., Szumlanski, C.L. and Weinshilboum, R.M. (1996) Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 6, 243-250.
27. Lachman, H.M., Morrow, B., Shprintzen, R., Veit, S., Parsia, S.S., Faedda, G., Goldberg, R., Kucherlapati, R. and Papolos, D.F. (1996) Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am. J. Med. Genet., 67, 468-472.
28. Kirov, G., Murphy, K.C., Arranz, M.J., Jones, I., McCandles, F., Kunugi, H., Murray, R.M., McGuffin, P., Collier, D.A., Owen, M.J. and Craddock, N. (1998) Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder. Mol. Psychiatry, 3, 342-345.
29. Fearon, E.R. (1997) Human cancer syndromes: clues to the origin and nature of cancer. Science, 278, 1043-1050.
30. Tanzi, R.E. (1999) A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders. J. Clin. Invest., 104, 1175-1179.
31. Berrettini, W. (1998) Progress and pitfalls: bipolar molecular linkage studies. J. Affect. Disord., 50, 287-297.
32. Gershon, E.S., Badner, J.A., Goldin, L.R., Sanders, A.R., Cravchik, A. and Detera-Wadleigh, S.D. (1998) Closing in on genes for manic-depressive illness and schizophrenia. Neuropsychopharmacology, 18, 233-242.
33. Kennedy, J.L., Basile, V.S. and Macciardi, F.M. (1999) Chromosome 4 Workshop Summary: Sixth World Congress on Psychiatric Genetics, Bonn, Germany, 6-10 October 1998. Am. J. Med. Genet., 88, 224-228.
34. Lappalainen, J., Long, J.C., Eggert, M., Ozaki, N., Robin, R.W., Brown, G.L., Naukkarinen, H., Virkkunen, M., Linnoila, M. and Goldman, D. (1998) Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations. Arch. Gen. Psychiatry, 55, 989-994.
35. Reich, T., Edenberg, H.J., Goate, A., Williams, J.T., Rice, J.P., Van Eerdewegh, P., Foroud, T., Hesselbrock, V., Schuckit, M.A., Bucholz, K. et al. (1998) Genome-wide search for genes affecting the risk for alcohol dependence. Am. J. Med. Genet., 81, 207-215.
36. Long, J.C., Knowler, W.C., Hanson, R.L., Robin, R.W., Urbanek, M., Moore, E., Bennett, P.H. and Goldman, D. (1998) Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am. J. Med. Genet., 81, 216-221.
37. Freedman, R., Adler, L.E. and Leonard, S. (1999) Alternative phenotypes for the complex genetics of schizophrenia. Biol. Psychiatry, 45, 551-558.
38. Schuckit, M.A. (1998) Biological, psychological and environmental predictors of the alcoholism risk: a longitudinal study. J. Stud. Alcohol, 59, 485-494.
39. Levy, D.L., Holzman, P.S., Matthysse, S. and Mendell, N.R. (1994) Eye tracking and schizophrenia: a selective review. Schizoph. Bull., 20, 47-62.
40. Arolt, V., Lencer, R., Purmann, S., Schürmann, M., Müller-Myhsok, B., Krecker, K. and Schwinger, E. (1999) Testing for linkage of eye tracking dysfunction and schizophrenia to markers on chromosomes, 6, 8, 9, 20, and 22 in families multiply affected with schizophrenia. Am. J. Med. Genet., 88, 603-606.
41. Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M. et al. (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl Acad. Sci. USA, 94, 587-592.
42. Myles-Worsley, M., Coon, H., McDowell, J., Brenner, C., Hoff, M., Lind, B., Bennett, P., Freedman, R., Clementz, B. and Byerley, W. (1999) Linkage of a composite inhibitory phenotype to a chromosome 22q locus in eight Utah families. Am. J. Med. Genet., 88, 544-550.
43. Schuckit, M.A. (1987) Studies of populations at high risk for the future development of alcoholism. Prog. Clin. Biol. Res., 241, 83-96.
44. Bauer, L.O. and Hesselbrock, V.M. (1999) P300 decrements in teenagers with conduct problems: implications for substance abuse risk and brain development. Biol. Psychiatry. 46, 263-272.
45. Turetsky, B., Colbath, E.A. and Gur, R.E. (1998) P300 subcomponent abnormalities in schizophrenia: II. Longitudinal stability and relationship to symptom change. Biol. Psychiatry, 43, 31-39.
46. Begleiter, H., Porjesz, B., Reich, T., Edenberg, H.J., Goate, A., Blangero, J., Almasy, L., Foroud, T., Van Eerdewegh, P., Polich, J. et al. (1990) Quantitative trait loci analysis of human event-related brain potentials: P3 voltage. Electroencephalogr. Clin. Neurophysiol., 108, 244-250.
47. Williams, J.T., Begleiter, H., Porjesz, B., Edenberg, H.J., Foroud, T., Reich, T., Goate, A., Van Eerdewegh, P., Almasy, L. and Blangero, J. (1999) Joint multipoint linkage analysis of multivariate qualitative and quantitative traits. II. Alcoholism and event-related potentials. Am. J. Hum. Genet., 65, 1148-1160.
48. Bates, J.E. and Wachs, T.D. (1994) Temperament: Individual Differences at the Interface of Biology and Behavior. American Psychological Association, Washington, DC.
49. Svrakic, D.M., Whitehead, C., Przybeck, T.R. and Cloninger, C.R. (1993) Differential diagnosis of personality disorders by the seven-factor model of temperament and character. Arch. Gen. Psychiatry, 50, 991-999.
50. Enns, M.W. and Cox, B.J. (1997) Personality dimensions and depression: review and commentary. Can. J. Psychiatry, 42, 274-284.
51. Bailey, A., Palferman, S., Heavey, L. and Le Couleur, A. (1998) Autism: the phenotype in relatives. J. Autism Dev. Disord., 28, 369-392.
52. Maher, B.S., Marazita, M.L., Moss, N.B. and Vanyukov, M.M. (1999) Segregation analysis of attention deficit hyperactivity disorder. Am. J. Med. Genet., 88, 71-78.
53. Risch, N. and Teng, J. (1998) The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling. Genome Res., 8, 1273-1288.
54. Burmeister, M. (1999) Basic concepts in the study of diseases with complex genetics. Biol. Psychiatry, 45, 522-532.
55. Malhotra, A.K. and Goldman, D. (1999) Benefits and pitfalls encountered in psychiatric genetic association studies. Biol. Psychiatry, 45, 544-550.
56. Heils, A., Teufel, A., Petri, S., Slober, G., Riederer, P., Bengel, D. and Lesch, K.P. (1996) Allelic variation of human serotonin transporter gene expression. J. Neurochem., 66, 2621-2624.
57. Lesch, K.P., Bengel, D., Heils, A., Sabol, S.Z., Greenberg, B.D., Petri, S., Benjamin, J., Muller, C.R., Hamer, D.H. and Murphy, D.L. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 274, 1527-1531.
58. Hill, E.M., Stoltenberg, S.F., Burmeister, M., Closser, M. and Zucker, R.A. (1999) Potential associations among genetic markers in the serotonergic system and the antisocial alcoholism subtype. Exp. Clin. Psychopharmacol., 7, 103-121.
59. Higley, J.D. and Bennett, A.J. (1999) Central nervous system serotonin and personality as variables contributing to excessive alcohol consumption in non-human primates. Alcohol Alcoholism, 34, 402-418.
60. Pihl, R.O. and LeMarquand, D. (1998) Serotonin and aggression and the alcohol-aggression relationship. Alcohol Alcoholism, 33, 55-65.
61. Flory, J.D., Manuck, S.B., Ferrell, R.E., Dent, K.M., Peters, D.G. and Muldoon, M.F. (1999) Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism. Mol. Psychiatry, 4, 93-96.
62. Gelernter, J., Kranzler, H., Coccaro, E.F., Siever, L.J. and New, A.S. (1998) Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects. Am. J. Psychiatry, 155, 1332-1338.
63. Ebstein, R.P., Gritsenko, I., Nemanov, L., Frisch, A., Osher, Y. and Belmaker, R.H. (1997) No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance. Mol. Psychiatry, 2, 224-226.
64. Van Tol, H.H., Bunzow, J.R., Guan, H.C., Sunahara, R.K., Seeman, P., Niznik, H.B. and Civelli, O. (1991) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature, 350, 610-614.
65. Ebstein, R.P., Novick, O., Umansky, R., Priel, B., Osher, Y., Blaine, D., Bennett, E.R., Nemanov, L., Katz, M. and Belmaker, R.H. (1996) Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nature Genet., 12, 78-80.
66. Benjamin, J., Li, L., Patterson, C., Greenberg, B.D., Murphy, D.L. and Hamer, D.H. (1996) Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nature Genet., 12, 81-84.
67. Gelernter, J., Kranzler, H., Coccaro, E., Siever, L., New, A. and Mulgrew, C.L. (1947) D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder, and control subjects. Am. J. Hum. Genet., 61, 1144-1152.
68. Sullivan, P.F., Fifield, W.J., Kennedy, M.A., Mulder, R.T., Sellman, J.D. and Joyce, P.R. (1998) No association between novelty seeking and the type 4 dopamine receptor gene (DRD4) in two New Zealand samples. Am. J. Psychiatry, 155, 98-101.
69. Paterson, A.D., Sunohara, G.A. and Kennedy, J.L. (1999) Dopamine D4 receptor gene: novelty or nonsense? Neuropsychopharmacology, 21, 3-16.
70. Ekelund, J., Lichtermann, D., Jarvelin, M.R. and Peltonen, L. (1999) Association between novelty seeking and the type 4 dopamine receptor gene in a large Finnish cohort sample. Am. J. Psychiatry, 156, 1453-1455.
71. Chen, C.C., Lu, R.B., Chen, Y.C., Wang, M.F., Chang, Y.C., Li, T.K. and Yin, S.J. (1999) Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism. Am. J. Hum. Gener., 65, 795-807.
72. Whitfield, J.B., Nightingale, B.N., Bucholz, K.K., Madden, P.A., Heath, A.C. and Martin, N.G. (1998) ADH genotypes and alcohol use and dependence in Europeans. Alcohol Clin. Exp. Res., 22, 1463-1469.
73. Ebstein, R.P., Levine, J., Geller, V., Auernach, J., Gritsenko, I. and Belmaker, R.H. (1998) Dopamine D4 receptor and serotonin transporter promoter in the determination of neonatal temperament. Mol. Psychiatry, 3, 238-246.
74. Kuhn, K.U., Meyer, K., Nothen, M.M., Gansicke, M., Papassotiropoulos, A. and Maier, W. (1999) Allelic variants of dopamine receptor D4 (DRD4) and serotonin receptor 5HT2c (HTR2c) and temperament factors: replication lests. Am. J. Med. Genet., 88, 168-172.
75. Wang, D.G., Fan, J.B., Siao, C.J., Berno, A., Young, P., Sapolsky, R., Ghandour, G., Perkins, N., Winchester, E., Spencer, J. et al. (1998) Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science, 280, 1077-1082.
76. Sapolsky, R.J., Hsie, L., Berno, A., Ghandour, G., Mittmann, M. and Fan, J.B. (1999) High-throughput polymorphism screening and genotyping with high-density oligonucleotide arrays. Genet. Anal., 14, 187-192.
77. Watson, S.J. and Akil, H. (1999) Gene chips and arrays revealed: a primer on their power and their uses. Biol. Psychiatry, 45, 533-543.
78. Risch, N. and Merikangas, K. (1996) The future of genetic studies of complex human diseases. Science, 273, 1516-1517.
79. Wahlsten, D. (1990) Insensitivity of the analysis of variance to heredity-environment interaction. Behav. Brain Sci., 31, 109-161.
80. Evans, W.E. and Relling, M.V. (1999) Pharmacogenomics: translating functional genomics into rational therapeutics. Science, 286, 487-491.
81. Catalano, M. (1999) The challenges of psychopharmacogenetics. Am. J. Hum. Genet., 65, 606-610.
82. Zanardi, R., Benedetti, F., Di Bella, D., Catalano, M. and Smeraldi, E. (2000) Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J. Clin. Psychopharmacol., 20, 105-107.
83. Smeraldi, E., Zanardi, R., Benedetti, F., Di Bella, D., Perez, J. and Catalano, M. (1998) Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol. Psychiatry, 3, 508-511.
84. Auerbach, J., Geller, V., Lezer, S., Shinwell, E., Belmaker, R.H., Levine, J. and Ebstein, R. (1999) Dopamine D4 receptor (D4DR) and serotonin transporter promoter (5-HTTLPR) polymorphisms in the determination of temperament in 2-month-old infants. Mol. Psychiatry, 4, 369-373.
85. Bellivier, F., Henry, C., Szoke, A., Schurhoff, F., Nosten-Bertrand, M., Feingold, J., Launay, J.M., Leboyer, M. and Laplanche, J.L. (1998) Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression. Neurosci. Lett., 255, 143-146.
86. Benedetti, F., Serretti, A., Colombo, C., Campori, E., Barbini, B., di Bella, D. and Smeraldi, E. (1999) Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. Am. J. Psychiatry, 156, 1450-1452.
87. Bengel, D., Greenberg, B., Cora-Locatelli, G., Altemus, M., Heils, A., Li, Q. and Murphy, D. (1999) Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Mol. Psychiatry, 4, 463-466.
88. Bocchetta, A., Piccardi, M.P., Palmas, M.A., Chillotti, C., Oi, A. and Del Zompo, M. (1999) Family-based association study between bipolar disorder and DRD2, DRD4, DAT, and SERT in Sardinia. Am. J. Med. Genet., 88, 522-526.
89. Devor, E.J., Magee, H.J., Dill-Devor, R.M., Gabel, J. and Black, D.W. (1999) Serotonin transporter gene (5-HTT) polymorphisms and compulsive buying. Am. J. Med. Genet., 88, 123-125.
90. Frisch, A., Postilnick, D., Rockah, R., Michaelovsky, E., Postilnick, S., Birman, E., Laor, N., Rauchverger, B., Kreinin, A., Poyurovsky, M. et al. (1999) Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways. Mol. Psychiatry, 4, 389-392.
91. Gutierrez, B., Pintor, L., Gasto, C., Rosa, A., Bertranpetit, J., Vieta, E. and Fananas, L. (1998) Variability in the serotonin transporter gene and increased risk for major depression with melancholia. Hum. Genet., 103, 319-322.
92. Hoehe, M.R., Wendel, B., Grunewald, I., Chiaroni, P., Levy, N., Morris-Rosendahl, D., Macher, J.P., Sander, T. and Crocq, M.A. (1998) Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders. Am. J. Med. Genet., 81, 1-3.
93. Kotler, M., Cohen, H., Kremer, I., Mel, H., Horowitz, R., Ohel, N., Gritsenko, I., Nemanov, L., Katz, M. and Ebstein, R. (1999) No association between the serotonin transporter promoter region (5-HTTLPR) and the dopamine D3 receptor (BalI D3DR) polymorphisms and heroin addiction [letter]. Mol. Psychiatry, 4, 313-314.
94. Kumakiri, C., Kodama, K., Shimizu, E., Yamanouchi, N., Okada, S., Noda, S., Okamoto, H., Sato, T. and Shirasawa, H. (1999) Study of the association between the serotonin transporter gene regulatory region polymorphism and personality traits in a Japanese population. Neurosci. Lett., 263, 205-207.
95. Malhotra, A.K., Goldman, D., Mazzanti, C., Clifton, A., Breier, A. and Pickar, D. (1998) A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics. Mol. Psychiatry, 3, 328-332.
96. Mendes de Oliveira, J.R., Otto, P.A., Vallada, H., Lauriano, V., Elkis, H., Lafer, B., Vasquez, L., Gentil, V., Passos-Bueno, M.R. and Zatz, M. (1998) Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene (5-HTT) in Brazilian patients affected by bipolar disorder and schizophrenia. Am. J. Med. Genet., 81, 225-227.
97. Murakami, F., Shimomura, T., Kotani, K., Ikawa, S., Nanba, E. and Adachi, K. (1999) Anxiety traits associated with a polymorphism in the serotonin transporter gene regulatory region in the Japanese. J. Hum Genet., 44, 15-17.
98. Oliveira, J.R. and Zatz, M. (1999) The study of genetic polymorphisms related to serotonin in Alzheimer's disease: a new perspective in a heterogenic disorder. Braz. J. Med. Biol. Res., 32, 463-467.
99. Rosenthal, N.E., Mazzanti, C.M., Barnett, R.L., Hardin, T.A., Turner, E.H., Lam, G.K., Ozaki, N. and Goldman, D. (1998) Role of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonality and seasonal affective disorder. Mol. Psychiatry, 3, 175-177.
100. Stein, M.B., Chartier, M.J., Kozak, M.V., King, N. and Kennedy, J.L. (1998) Genetic linkage to the serotonin transporter protein and 5HT2A receptor genes excluded in generalized social phobia. Psychiatry Res., 81, 283-291.
101. Stober, G., Jatzke, S., Heils, A., Jungkunz, G., Fuchs, E., Knapp, M., Riederer, P. and Lesch, K.P. (1998) Susceptibility for schizophrenia is not influenced by a functional insertion/deletion variant in the promoter of the serotonin transporter gene. Eur. Arch. Psychiatry Clin. Neurosci., 248, 82-86.
102. Turker, T., Sodmann, R., Goebel, U., Jatzke, S., Knapp, M., Lesch, K.P., Schuster, R., Schutz, H., Weiler, G. and Stober, G. (1998) High ethanol tolerance in young adults is associated with the low-activity variant of the promoter of the human serotonin transporter gene. Neurosci. Lett., 248, 147-150.
103. Bellivier, F., Leboyer, M., Courtet, P., Buresi, C., Beaufils, B., Samolyk, D., Allilaire, J.F., Feingold, J., Mallet, J. and Malafosse, A. (1998) Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch. Gen. Psychiatry, 55, 33-37.
104. New, A.S., Gelernter, J., Yovell, Y., Trestman, R.L., Nielsen, D.A., Silverman, J., Mitropoulou, V. and Siever, L.J. (1998) Tryptophan hydroxylase genotype is associated with impulsive-aggression measures: a preliminary study. Am. J. Med. Genet., 81, 13-17.
105. Gade, R., Muhleman, D., Blake, H., MacMurray, J., Johnson, P., Verde, R., Saucier, G. and Comings, D.E. (1998) Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse. Mol. Psychiatry, 3, 50-60.
106. Karayiorgou, M., Sobin, C., Blundell, M.L., Galke, B.L., Malinova, L., Goldberg, P., Ott, J. and Gogos, J.A. (1999) Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol. Psychiatry, 45, 1178-1189.
107. Kunugi, H., Ishida, S., Kato, T., Tatsumi, M., Sakai, T., Hattori, M., Hirose, T. and Nanko, S. (1999) A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders. Mol. Psychiatry, 4, 393-395.
108. Spurlock, G., Heils, A., Holmans, P., Williams, J., Um, D.S., Cardno, A., Murphy, K.C., Jones, L., Buckland, P.R., McGuffin, P. et al. (1998) A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter. Mol. Psychiatry, 3, 42-49.
109. Yu, Y.W., Tsai, S.J., Lin, C.H., Hsu, C.P., Yang, K.H. and Hong, C.J. (1999) Serotonin-6 receptor variant (C267T) and clinical response to clozapine. Neuroreport, 10, 1231-1233.
110. Lassig, J.P., Vachirasomtoon, K., Hartzell, K., Leventhal, M., Courchesne, E., Courchesne, R., Lord, C., Leventhal, B.L. and Cook Jr, E.H. (1999) Physical mapping of the serotonin 5-HT(7) receptor gene (HTR7) to chromosome 10 and pseudogene (HTR7P) to chromosome 12, and testing of linkage disequilibrium between HTR7 and autistic disorder. Am. J. Med. Genet., 88, 472-475.
111. Williams, H.J., Bray, N., Murphy, K.C., Cardno, A.G., Jones, L.A. and Owen, M.J. (1999) No evidence for allelic association between schizophrenia and a functional variant of the human dopamine β-hydroxylase gene (DBH). Am. J. Med. Genet., 88, 557-559.
112. Kirov, G., Jones, I., McCandless, F., Craddock, N. and Owen, M. (1999) Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5. Mol. Psychiatry, 4, 558-565.
113. Savoye, C., Laurent, C., Amadeo, S., Gheysen, F., Leboyer, M., Lejeune, J., Zarifian, E. and Mallet, J. (1998) No association between dopamine D1, D2, and D3 receptor genes and manic-depressive illness. Biol. Psychiatry, 44, 644-647.
114. Li, T., Arranz, M., Aitchison, K.J., Bryant, C., Liu, X., Kerwin, R.W., Murray, R., Sham, P. and Collier, D.A. (1998) Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia. Schizoph. Res., 32, 87-92.
115. Goldman, D., Urbanek, M., Guenther, D., Robin, R. and Long, J.C. (1998) A functionally deficient DRD2 variant [Ser311Cys] is not linked to alcoholism and substance abuse. Alcohol, 16, 47-52.
116. Devor, E.J., Dill-Devor, R.M. and Magee, H.J. (1998) The BalI and MspI polymorphisms in the dopamine D3 receptor gene display linkage disequilibrium with each other but no association with Tourette syndrome. Psychiatr. Genet., 8, 49-52.
117. Duaux, E., Gorwood, P., Griffon, N., Bourdel, M.C., Sautel, F., Sokoloff, P., Schwartz, J.C., Ades, J., Loo, H. and Poirier, M.F. (1998) Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence. Mol. Psychiatry, 3, 333-336.
118. Hawi, Z., McCabe, U., Straub, R.E., O'Neil, A., Kendler, K.S., Walsh, D. and Gill, M. (1998) Examination of new and reported data of the DRD3/ MscI polymorphism: no support for the proposed association with schizophrenia. Mol. Psychiatry, 3, 150-155.
119. Okuyama, Y., Ishiguro, H., Toru, M. and Arinami, T. (1999) A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia. Biochem. Biophys. Res. Commun., 258, 292-295.
120. Serretti, A., Macciardi, F., Cusin, C., Lattuada, E., Lilli, R., Di Bella, D., Catalano, M. and Smeraldi, E. (1999) No interaction of GABA(A) α-1 subunit and dopamine receptor D4 exon 3 genes in symptomatology of major psychoses. Am. J. Med. Genet., 88, 44-49.
121. Asherson, P., Mant, R., Williams, N., Cardno, A., Jones, L., Murphy, K., Collier, D.A., Nanko, S., Craddock, N., Morris, S. et al. (1998) A study of chromosome 4p markers and dopamine D5 receptor gene in schizophrenia and bipolar disorder. Mol. Psychiatry, 3, 310-320.
122. Schmidt, L.G., Harms, H., Kuhn, S., Rommelspacher, H. and Sander, T. (1998) Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. Am. J. Psychiatry, 155, 474-478.
123. Waldman, I.D., Rowe, D.C., Abramowitz, A., Kozel, ST., Mohr, J.H., Sherman, S.L., Cleveland, H.H., Sanders, M.L., Gard, J.M. and Stever, C. (1998) Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am. J. Hum. Genet., 63, 1767-1776.
124. Sander, T., Harms, H., Rommelspacher, H., Hoehe, M. and Schmidt, L.G. (1998) Possible allelic association of a tyrosine hydroxylase polymorphism with vulnerability to alcohol-withdrawal delirium. Psychiatr. Genet., 8, 13-17.
125. Souery, D., Lipp, O., Rivelli, S.K., Massat, I., Serretti, A., Cavallini, C., Ackenheil, M., Adolfsson, R., Aschauer, H., Blackwood, D. et al. (1999) Tyrosine hydroxylase polymorphism and phenotypic heterogeneity in bipolar affective disorder: a multicenter association study. Am. J Med. Genet., 88, 527-532.
126. Barr, C.L., Wigg, K., Malone, M., Schachar, R., Tannock, R., Roberts, W. and Kennedy, J.L. (1999) Linkage study of catechol-O-methyltransferase and attention-deficit hyperactivity disorder. Am. J. Med. Genet., 88, 710-713.
127. Chen, C.H., Lee, Y.R., Chung, M.Y., Wei, F.C., Koong, F.J., Shaw, C.K., Yeh, J.I. and Hsiao, K.J. (1999) Systematic mutation analysis of the catechol O-methyltransferase gene as a candidate gene for schizophrenia. Am. J. Psychiatry, 156, 1273-1275.
128. Kotler, M., Barak, P., Cohen, H., Averbuch, I.E., Grinshpoon, A., Gritsenko, I., Nemanov, L. and Ebstein, R.P. (1999) Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity. Am. J. Med. Genet., 88, 628-633.
129. Kunugi, H., Vallada, H.P., Sham, P.C., Hoda, F., Arranz, M.J., Li, T., Nanko, S., Murray, R.M., McGuffin, P., Owen, M. et al. (1997) Catechol-O-methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families. Psychiatr. Genet., 7, 97-101.
130. Mynett-Johnson, L.A., Murphy, V.E., Claffey, E., Shields, D.C. and McKeon, P. (1998) Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene. Psychiatr. Genet., 8, 221-225.
131. Ohmori, O., Shinkai, T., Kojima, H., Terao, T., Suzuki, T., Mita, T. and Abe, K. (1998) Association study of a functional catechol-O-methyl-transferase gene polymorphism in Japanese schizophrenics. Neurosci. Lett., 243, 109-112.
132. Owen, D., Du, L., Bakish, D., Lapierre, Y.D. and Hrdina, P.D. (1999) Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depression. Psychiatry Res., 87, 1-5.
133. Stober, G., Hebebrand, J., Cichon, S., Bruss, M., Bonisch, H., Lehmkuhl, G., Poustka, F., Schmidt, M., Remschmidt, H., Propping, P. and Nothen, M.M. (1999) Tourette syndrome and the norepinephrine transporter gene: results of a systematic mutation screening. Am. J. Med. Genet., 88, 158-163.
134. Serretti, A., Macciardi, F., Cusin, C., Lattuada, E., Lilli, R., Di Bella, D., Catalano, M. and Smeraldi, E. (1998) GABAA α-1 subunit gene not associated with depressive symptomatology in mood disorders. Psychiatr. Genet., 8, 251-254.
135. Sander, T., Gscheidel, N., Wendel, B., Samochowiec, J., Smolka, M., Rommelspacher, H., Schmidt, L.G. and Hoehe, M.R. (1998) Human μ-opioid receptor variation and alcohol dependence. Alcohol Clin. Exp. Res., 22, 2108-2110.
136. Smolka, M., Sander, T., Schmidt, L.G., Samochowiec, J., Rommelspacher, H., Gscheidel, N., Wendel, B. and Hoehe, M.R. (1999) μ-opioid receptor variants and dopaminergic sensitivity in alcohol withdrawal. Psychoneuroendocrinohgy, 24, 629-638.
137. Town, T., Abdullah, L., Crawford, F., Schinka, J., Ordorica, P.I., Francis, E., Hughes, P., Duara, R. and Mullan, M. (1999) Association of a functional μ-opioid receptor allele (+118A) with alcohol dependency. Am. J. Med. Genet., 88, 458-461.
138. Bond, C., LaForge, K.S., Tian, M., Melia, D., Zhang, S., Borg, L., Gong, J., Schluger, J., Strong, J.A., Leal, S.M. et al. (1998) Single-nucleotide polymorphism in the human μ opioid receptor gene alters β-endorphin binding and activity: possible implications for opiate addiction. Proc. Natl Acad. Sci. USA, 95, 9608-9613.
139. Franke, P., Nothen, M.M., Wang, T., Neidt, H., Knapp, M., Lichtermann, D., Weiffenbach, O., Mayer, P., Hollt, V., Propping, P. and Maier, W. (1999) Human δ-opioid receptor gene and susceptibility to heroin and alcohol dependence. Am. J. Med. Genet., 88, 462-464.
140. Sun, F., Tsuritani, I., Honda, R., Ma, Z.Y. and Yamada, Y. (1999) Association of genetic polymorphisms of alcohol-metabolizing enzymes with excessive alcohol consumption in Japanese men. Hum. Genet., 105, 295-300.
141. Tanaka, E. (1999) Update: genetic polymorphism of drug metabolizing enzymes in humans. J. Clin. Pharm. Ther., 24, 323-329.
142. Antonarakis, S.E., Blouin, J.L., Lasseter, V.K., Gehrig, C., Radhakrishna, U., Nestadt, G., Housman, D.E., Kazazian, H.H., Kalman, K., Gutman, G. et al. (1999) Lack of linkage or association between schizophrenia and the polymorphic trinucleotide repeat within the KCNN3 gene on chromosome Iq21. Am. J. Med. Genet., 88, 348-351.
143. Breen, G., Fox, H., Glen, I., Collier, D., Shaw, D. and St Clair, D. (1999) Association study of the CACN1A4 (SCA6) triplet repeat and schizophrenia. Psychiatr. Genet., 9, 111-113.
144. Joo, E.J., Lee, J.H., Cannon, T.D. and Price, R.A. (1999) Possible association between schizophrenia and a CAG repeat polymorphism in the spinocerebellar ataxia type 1 (SCA1) gene on human chromosome 6p23. Psychiatr. Genet., 9, 7-11.
145. Joober, R., Benkelfat, C., Brisebois, K., Toulouse, A., Lafreniere, R.G., Turecki, G., Lal, S., Bloom, D., Labelle, A., Lalonde, P. et al. (1999) Lack of association between the hSKCa3 channel gene CAG polymorphism and schizophrenia. Am. J. Med. Genet., 88, 154-157.
146. Meissner, B., Purmann, S., Schurmann, M., Zuhlke, C., Lencer, R., Arolt, V., Muller-Myhsok, B., Morris-Rosendahl, D.J. and Schwinger, E. (1999) hSkca3: a candidate gene for schizophrenia? Psychiatr. Genet., 9, 91-96.
147. Moriniere, S., Saada, C., Holbert, S., Sidransky, E., Galat, A., Ginns, E., Rapoport, J.L. and Neri, C. (1999) Detection of polyglutamine expansion in a new acidic protein: a candidate for childhood onset schizophrenia? Mol. Psychiatry, 4, 58-63.
148. Tsai, M.T., Shaw, C.K., Hsiao, K.J. and Chen, C.H. (1999) Genetic association study of a polymorphic CAG repeats array of calcium-activated potassium channel (KCNN3) gene and schizophrenia among the Chinese population from Taiwan. Mol. Psychiatry, 4, 271-273.
149. Wittekindt, O., Schwab, S.G., Burgert, E., Knapp, M., Albus, M., Lerer, B., Hallmayer, J., Rietschel, M., Segman, R., Borrmann, M. et al. (1999) Association between hSKCa3 and schizophrenia not confirmed by transmission